October 2021 Price Concessions 2nd Update

THIS CONTENT HAS NOW EXPIRED

The Department of Health and Social Care (DHSC) has today granted the following list of price concessions:

Drug Pack size Price Concession
Clomipramine 50mg capsules 28 £8.60
Glyceryl trinitrate 400micrograms/dose pump sublingual spray 180 £2.83
Hypromellose 0.5% eye drops 10 £1.17
Lercanidipine 10mg tablets 28 £2.99
Lercanidipine 20mg tablets 28 £2.96
Loratadine 5mg/5ml oral solution 100 £6.92
Orlistat 120mg capsules 84 £25.50
Perindopril erbumine 8mg tablets 30 £2.14
Tolbutamide 500mg tablets 28 £26.00

The DHSC previously announced (15.10.2021) the following list of price concessions:

Drug Pack size Price Concession
Glyceryl trinitrate 400micrograms/dose pump sublingual spray 200 £2.83
Lamotrigine 5mg dispersible tablets sugar free 28 £8.43
Methocarbamol 750mg tablets 100 £12.37
Pioglitazone 45mg tablets 28 £2.40
Timolol 0.25% eye drops 5 £4.16
Timolol 0.5% eye drops 5 £4.10
Trimethoprim 50mg/5ml oral suspension sugar free 100 £10.99
Ursodeoxycholic acid 250mg capsules 60 £10.53

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated October 2021 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. 

 

Join us on 7th May to discuss our work and progress in key areas, as well as sharing views on the issues that matter to you.

Click Here